GERN Competitors & Alternatives
Compare Geron Corporation with similar stocks in the same industry
Biotechnology
GERN
Main Stock$1.35
Tradestie Score
61
Market Cap
$899.60M
Revenue Growth
0.3%
Analyst Upside
+151.9%
Top Competitors
222 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SEPN
Septerna, Inc. Common Stock
|
$36.57
|
$847.12M | - | 58 | Compare |
|
XNCR
Xencor, Inc.
|
$14.08
|
$843.75M | - | 61 | Compare |
|
GHRS
GH Research PLC Ordinary Shares
|
$23.61
|
$841.74M | - | 53 | Compare |
|
KOD
Kodiak Sciences Inc Common Stock
|
$37.05
|
$832.47M | - | 55 | Compare |
|
URGN
UroGen Pharma Ltd. Ordinary Shares
|
$35.15
|
$824.20M | - | 57 | Compare |
|
IVA
Inventiva S.A. American Depository Shares
|
$3.71
|
$821.84M | - | 49 | Compare |
|
MBX
MBX Biosciences, Inc. Common Stock
|
$46.39
|
$800.41M | - | 51 | Compare |
|
IOVA
Iovance Biotherapeutics, Inc. Common Stock
|
$4.44
|
$799.70M | - | 65 | Compare |
|
KURA
Kura Oncology, Inc.
|
$10.38
|
$798.53M | - | 53 | Compare |
|
VIR
Vir Biotechnology, Inc. Common Stock
|
$10.16
|
$791.82M | - | 61 | Compare |
More GERN Analysis
Data updated: Jun 23, 2026 | Industry: Biotechnology (SIC 2834)
222 stocks in this industry